Pharmacogenomics logo Future Medicine logo

Pharmacogenomics provides the community with an essential resource for keeping abreast of the latest developments in new pharmacogenomic initiatives, emerging technologies for accessing genomic information and the development of novel diagnostic products and strategies.

Publisher: Future Medicine

Volume 10, Number 11, November 2009
Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content

< previous issue | next issue > | all issues

Can the pharmacogenetics of GST gene polymorphisms predict the dose of busulfan in pediatric hematopoietic stem cell transplantation?
pp. 1729-1732(4)
Authors: Ansari, Marc; Krajinovic, Maja

News & Views in ... Pharmacogenomics
pp. 1733-1735(3)

Research Highlights
pp. 1737-1741(5)
Authors: Müller, Daniel J; Sturgess, Jessica E

Common genetic variation in the ABCB1 gene is associated with the cholesterol-lowering effect of simvastatin in males
pp. 1743-1751(9)
Authors: Becker, Matthijs L; Visser, Loes E; van Schaik, Ron HN; Hofman, Albert; Uitterlinden, André G; Stricker, Bruno HCh

Thiopurine S-methyltransferase pharmacogenetics in a large-scale healthy Italian-Caucasian population: differences in enzyme activity
pp. 1753-1765(13)
Authors: Serpe, Loredana; Calvo, Pier Luigi; Muntoni, Elisabetta; D'Antico, Sergio; Giaccone, Mario; Avagnina, Alessandra; Baldi, Maurizio; Barbera, Cristiana; Curti, Franco; Pera, Angelo; Eandi, Mario; Zara, Gian Paolo; Canaparo, Roberto

Genetic polymorphisms of drug-metabolizing enzymes and anti-TB drug-induced hepatitis
pp. 1767-1779(13)
Authors: Kim, Sang-Heon; Kim, Sang-Hoon; Bahn, Joon-Woo; Kim, Yoon-Keun; Chang, Yoon-Seok; Shin, Eun-Soon; Kim, Youn-Seup; Park, Jae-Seuk; Kim, Bo-Hyung; Jang, In-Jin; Song, Junghan; Kim, Seung-Hyun; Park, Hae-Sim; Min, Kyung-Up; Jee, Young-Koo

Presence of CYP2C9*3 allele increases risk for hypoglycemia in Type 2 diabetic patients treated with sulfonylureas
pp. 1781-1787(7)
Authors: Ragia, Georgia; Petridis, Ioannis; Tavridou, Anna; Christakidis, Dimitrios; Manolopoulos, Vangelis G

Genetic variation in CYP27B1 is associated with congestive heart failure in patients with hypertension
pp. 1789-1797(9)
Authors: Wilke, Russell A; Simpson, Robert U; Mukesh, Bickol N; Bhupathi, Satya V; Dart, Richard A; Ghebranious, Nader R; McCarty, Catherine A

Clopidogrel pharmacogenomics and risk of inadequate platelet inhibition: US FDA recommendations
pp. 1799-1817(19)
Authors: Ellis, Kyle J; Stouffer, George A; McLeod, Howard L; Lee, Craig R

Host genetic determinants of spontaneous hepatitis C clearance
pp. 1819-1837(19)
Authors: Rauch, Andri; Gaudieri, Silvana; Thio, Chloe; Bochud, Pierre-Yves

Pharmacogenomics in acute myeloid leukemia
pp. 1839-1851(13)
Authors: Roumier, Christophe; Cheok, Meyling H

Survey on warfarin pharmacogenetic testing among anticoagulation providers
pp. 1853-1860(8)
Authors: Kadafour, Maha; Haugh, Roshanak; Posin, Monica; Kayser, Steven R; Shin, Jaekyu

Acknowledgements
pp. 1880-1880(1)

Erratum
pp. 1882-1882(1)

< previous issue | next issue > | all issues

Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages.
Page Help Click here for Page Help
Shopping cart
Tools
Sign in






Need to register?
Sign up here
Text size: A | A | A | A